Search This Blog

Thursday, September 22, 2022

Albireo in $115 Million Royalty Monetization Agreement

  • Upfront payment for continued clinical development and commercialization of Bylvay®

  • Sagard to receive a mid-single digit average royalty rate on Bylvay sales

  • No liens against Bylvay intellectual property

  • Right to buy out Sagard’s investment at any time


No comments:

Post a Comment

Note: Only a member of this blog may post a comment.